Ossiam’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.8M | Buy |
45,879
+6,522
| +17% | +$2.89M | 0.3% | 55 |
|
|
2026
Q1 | $17.6M | Buy |
39,357
+21,763
| +124% | +$10.1M | 0.31% | 53 |
|
|
2025
Q4 | $7.98M | Buy |
17,594
+4,654
| +36% | +$2.01M | 0.16% | 74 |
|
|
2025
Q3 | $5.07M | Buy |
12,940
+8,340
| +181% | +$3.49M | 0.07% | 203 |
|
|
2025
Q2 | $2.05M | Sell |
4,600
-66,608
| -94% | -$30.7M | 0.02% | 267 |
|
|
2025
Q1 | $34.5M | Buy |
71,208
+6,375
| +10% | +$2.97M | 0.48% | 43 |
|
|
2024
Q4 | $26.1M | Buy |
64,833
+435
| +0.7% | +$202K | 0.45% | 43 |
|
|
2024
Q3 | $30M | Sell |
64,398
-1,107
| -2% | -$532K | 0.58% | 40 |
|
|
2024
Q2 | $30.7M | Buy |
65,505
+54,411
| +490% | +$23.6M | 0.58% | 43 |
|
|
2024
Q1 | $4.64M | Buy |
11,094
+2,100
| +23% | +$888K | 0.08% | 148 |
|
|
2023
Q4 | $3.66M | Buy |
8,994
+1,238
| +16% | +$457K | 0.06% | 145 |
|
|
2023
Q3 | $2.7M | Buy |
7,756
+227
| +3% | +$79.4K | 0.05% | 170 |
|
|
2023
Q2 | $2.65M | Sell |
7,529
-91,574
| -92% | -$30.9M | 0.05% | 182 |
|
|
2023
Q1 | $31.2M | Buy |
99,103
+3,044
| +3% | +$913K | 0.65% | 41 |
|
|
2022
Q4 | $27.7M | Buy |
96,059
+1,765
| +2% | +$538K | 0.72% | 41 |
|
|
2022
Q3 | $27.3M | Sell |
94,294
-1,764
| -2% | -$508K | 0.79% | 29 |
|
|
2022
Q2 | $27.1M | Buy |
96,058
+1,984
| +2% | +$531K | 0.81% | 35 |
|
|
2022
Q1 | $24.6M | Buy |
94,074
+4,020
| +4% | +$954K | 0.64% | 37 |
|
|
2021
Q4 | $19.8M | Buy |
90,054
+87,369
| +3,254% | +$17M | 0.52% | 51 |
|
|
2021
Q3 | $487K | Buy |
2,685
+393
| +17% | +$76.7K | 0.01% | 315 |
|
|
2021
Q2 | $462K | Sell |
2,292
-2,676
| -54% | -$560K | 0.01% | 326 |
|
|
2021
Q1 | $1.07M | Buy |
4,968
+4,711
| +1,833% | +$1.03M | 0.03% | 212 |
|
|
2020
Q4 | $61K | Buy |
257
+205
| +394% | +$47K | ﹤0.01% | 378 |
|
|
2020
Q3 | $14K | Sell |
52
-2
| -4% | -$552 | ﹤0.01% | 379 |
|
|
2020
Q2 | $16K | Sell |
54
-3,357
| -98% | -$910K | ﹤0.01% | 412 |
|
|
2020
Q1 | $812K | Buy |
3,411
+2,858
| +517% | +$656K | 0.06% | 185 |
|
|
2019
Q4 | $121K | Sell |
553
-347
| -39% | -$70.2K | 0.01% | 367 |
|
|
2019
Q3 | $152K | Buy |
900
+590
| +190% | +$104K | 0.01% | 346 |
|
|
2019
Q2 | $57K | Sell |
310
-17,472
| -98% | -$3.05M | ﹤0.01% | 409 |
|
|
2019
Q1 | $3.27M | Sell |
17,782
-9,563
| -35% | -$1.77M | 0.27% | 77 |
|
|
2018
Q4 | $4.53M | Buy |
+27,345
| New | +$4.74M | 0.68% | 44 |
|
Other funds holding VRTX
Ossiam's VRTX Position: Q2 2026 in Review
Ossiam increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, buying an estimated $2.89M and bringing the position to 45,879 shares worth $22.8M. The position accounts for 0.3% of the portfolio, ranked #55.
Ossiam first reported a position in VRTX in Q4 2018 and has held it in 31 quarters since. The position peaked at $34.5M in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Ossiam held 45,879 shares of Vertex Pharmaceuticals worth $22.8M as of Q2 2026.
- Ossiam bought 6,522 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.89M.
- Vertex Pharmaceuticals made up 0.3% of Ossiam's portfolio in Q2 2026, its #55 holding.
- Ossiam first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
- Ossiam's Vertex Pharmaceuticals position peaked at $34.5M in Q1 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.